Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone

@article{Harvey2011PerformanceAI,
  title={Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone},
  author={Philip D. Harvey and M. Ogasa and J. Cucchiaro and A. Loebel and R. Keefe},
  journal={Schizophrenia Research},
  year={2011},
  volume={127},
  pages={188-194}
}
  • Philip D. Harvey, M. Ogasa, +2 authors R. Keefe
  • Published 2011
  • Psychology, Medicine
  • Schizophrenia Research
  • BACKGROUND Improving cognitive functioning in people with schizophrenia is a major treatment goal. In addition, interview-based measures have been developed to supplement performance-based assessments. However, few data are available regarding whether interview-based measures are sensitive to treatment-related changes. METHODS Adult outpatients who met DSM-IV criteria for schizophrenia or schizoaffective disorder were randomized to 21 days of double-blind treatment with lurasidone 120 mg once… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale
    • 30
    • Open Access

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 37 REFERENCES
    Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
    • 863
    • Open Access
    The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
    • 1,342
    • Highly Influential
    • Open Access
    Self-assessment of functional status in schizophrenia.
    • 180
    • Open Access